Catherine C Fahey

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 9

Top Topics

Binding Protein

Squamous Cell Carcinoma

Top Venues

Journal for immunotherapy of cancer

Expert review of anticancer therapy

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Catherine C Fahey, W Kimryn Rathmell
Clinical Trials-Real-World Data to Build a Future for Our Patients. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (18) (2024)
Catherine C Fahey, W Kimryn Rathmell
Clinical Trials-Real-World Data to Build a Future for Our Patients. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Catherine C Fahey, Thomas J Gracie, Douglas B Johnson
Immune checkpoint inhibitors: maximizing benefit whilst minimizing toxicity. Expert review of anticancer therapy (2023)
Jamaal L James, Brandie C Taylor, Margaret L Axelrod, Xiaopeng Sun, Lindsey N Guerin, Paula I Gonzalez-Ericsson, Yu Wang, Violeta Sanchez, Catherine C Fahey, Melinda E Sanders, Yaomin Xu, Emily Hodges, Douglas B Johnson, Justin M Balko
Polycomb repressor complex 2 suppresses interferon-responsive MHC-II expression in melanoma cells and is associated with anti-PD-1 resistance. Journal for immunotherapy of cancer 11 (11) (2023)
Catherine C Fahey, Thomas J Gracie, Douglas B Johnson
Immune checkpoint inhibitors: maximizing benefit whilst minimizing toxicity. Expert review of anticancer therapy (2023)
Jamaal L James, Brandie C Taylor, Margaret L Axelrod, Xiaopeng Sun, Lindsey N Guerin, Paula I Gonzalez-Ericsson, Yu Wang, Violeta Sanchez, Catherine C Fahey, Melinda E Sanders, Yaomin Xu, Emily Hodges, Douglas B Johnson, Justin M Balko
Polycomb repressor complex 2 suppresses interferon-responsive MHC-II expression in melanoma cells and is associated with anti-PD-1 resistance. Journal for immunotherapy of cancer 11 (11) (2023)
Jamaal L James, Brandie C Taylor, Margaret L Axelrod, Xiaopeng Sun, Lindsey N Guerin, Paula I Gonzalez-Ericsson, Yu Wang, Violeta Sanchez, Catherine C Fahey, Melinda E Sanders, Yaomin Xu, Emily Hodges, Douglas B Johnson, Justin M Balko
Polycomb repressor complex 2 suppresses interferon-responsive MHC-II expression in melanoma cells and is associated with anti-PD-1 resistance. Journal for immunotherapy of cancer 11 (11) (2023)
Catherine C Fahey, Caroline A Nebhan, Sally York, Nancy B Davis, Paula J Hurley, Jennifer B Gordetsky, Kerry R Schaffer
Metastatic Penile Squamous Cell Carcinoma Responsive to Enfortumab Vedotin. International journal of molecular sciences 24 (22) (2023)
Jamaal L James, Brandie C Taylor, Margaret L Axelrod, Xiaopeng Sun, Lindsey N Guerin, Paula I Gonzalez-Ericsson, Yu Wang, Violeta Sanchez, Catherine C Fahey, Melinda E Sanders, Yaomin Xu, Emily Hodges, Douglas B Johnson, Justin M Balko
Polycomb repressor complex 2 suppresses interferon-responsive MHC-II expression in melanoma cells and is associated with anti-PD-1 resistance. Journal for immunotherapy of cancer 11 (11) (2023)